Member Info for Laura2022

Xataxx

Good evening, would you be able to summarise your main take aways please .

As we close out 2025, it is clear we are in an era of significant change; one where the shift toward MIDD is not a trend, but a fundamental response to the high-risk landscape of modern R&D. Precise, early decisions – informed by models – offer the clearest path to improving the narrow margins of clinical success.

As we look toward 2026, our goal remains the same: to translate biological complexity into data-driven insights that can move programmes forward. It has been a privilege to navigate these challenges alongside our partners – expanding our reach into new therapeutic areas and modalities – and we remain committed to providing the clarity needed to bring life-changing therapies to the clinic and to the patients that need them.

Ian

Says the person on possibly the biggest fraud on AIM

ianlaurence

Posted in: ENET

Posts: 134

Huge upside here on any news15 Dec 2025 13:08

Not for the faint hearted that’s for sure..

Big risk v reward.. fortune favours the brave

Enjoy Xmas Ian

Company is undertaking a fundraise to pay initial launch costs ranging from field work to lenders' and other financiers' fees and costs associated with the full funding package, including the repayment of working capital facilities drawn to pay for such costs to date.

More funding

Same stuff goes on FTSE too

Petrofrac , Wood Group and any others

Maluta

It would be so obvious and easy to stop...surely

Picked up more into close

What chance do Investors have when AIM, NOMADs allow 5-10yrs of apparent lies or half truths on VAST PREM RRR, TRX and many others

And then ...once the musical chairs stop ..just do a de -list , related party RTO etc

Truly depressing stuff

Ree scheduled with today's RNS in mind amd therefore have some solid answers

announces that the webinar previously proposed for Tuesday 23 December 2025 has now been rescheduled for Monday, 22 December 2025 at 17:00 GMT.

Now 4.3p on bid :)

Filtered the canary..in the cage with them

That was quick

Troll gone in 30 seconds

Don't be bitter because you sold TGP too early 'l

Powering

Power finish above 10p would setup tomorrow nicely

Both for me Rick

Drug development is moving at an incredible pace.  As programmes become more complex, the ability to make informed decisions earlier in the process has become a necessity rather than a luxury.

In an era where data science and AI are redefining the boundaries of what is possible, the challenge for drug developers is no longer a lack of information, but how to manage and translate that data into clear, reliable insight. Throughout 2025, it has been exciting to see Model-Informed Drug Development (MIDD) take a more central role in meeting this challenge. We have been equally excited to launch our new Biometrics service, which allows us to offer wider support for both programme strategy and delivery – bridging the gap between predictive modelling and clinical evidence and strengthening confidence in key development decisions.

Ultimately, our goal isn't just to help teams move faster – it’s to help them move with more confidence (the industry’s most effective sleep aid!).

Ive added to my 8.6p shares at 9.6p

I was in WHI recently

Did 450% from Oct to Dec as a takeover came

I'll take those odds of x 4

Still got till 23rd Jan 2026 too